Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.

Nagle, Christina M; Ibiebele, Torukiri I; DeFazio, Anna; Protani, Melinda M; Webb, Penelope M

Nagle, Christina M; Ibiebele, Torukiri I; DeFazio, Anna; Protani, Melinda M; Webb, Penelope M.

Afiliação

Nagle CM; Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia. Electronic address: christina.nagle@qimrberghofer.edu.au.
Ibiebele TI; Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia.
DeFazio A; Department of Gynaecological Oncology, Westmead Hospital and Westmead Institute for Cancer Research, University of Sydney at the Westmead Millennium Institute, Westmead, New South Wales 2145, Australia.
Protani MM; Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia.
Webb PM; Gynaecological Cancers Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia.

Cancer Epidemiol ; 39(2): 196-9, 2015 Apr.

Article em En | MEDLINE | ID: mdl-25666512

Assuntos

Acetaminofen/uso terapêutico; Anti-Inflamatórios não Esteroides/uso terapêutico; Aspirina/uso terapêutico; Neoplasias Ovarianas/tratamento farmacológico; Idoso; Feminino; Humanos; Pessoa de Meia-Idade; Neoplasias Ovarianas/mortalidade; Fatores de Risco

Palavras-chave

Aspirin; Mortality; NSAIDs; Ovarian cancer; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Anti-Inflamatórios não Esteroides / Aspirina / Acetaminofen Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google